Mesenchymal stem cell-associated lncRNA in osteogenic differentiation

Biomed Pharmacother. 2019 Jul:115:108912. doi: 10.1016/j.biopha.2019.108912. Epub 2019 Apr 29.

Abstract

Mesenchymal stem cells (MSCs) have the ability to differentiate into multiple cell types, including osteogenic, chondrogenic and adipogenic lineages. Osteogenic differentiation of MSCs plays a critical role in bone tissue engineering. Inducing MSC osteogenesis represents a potential treatment that promotes bone formation and bone regeneration. Recently, long non-coding RNA (lncRNA) was shown to participate in the occurrence and development of various diseases. Different lncRNA expression patterns can regulate the cell cycle, proliferation, metastasis, immunobiology and differentiation. With the recent extensive study of lncRNAs, an increasing number of lncRNAs are being studied in the MSC field. Furthermore, some lncRNAs have been confirmed to regulate MSC osteogenesis. Therefore, here, we review research concerning lncRNA in osteogenic differentiation of MSCs and highlight the importance of lncRNA in bone formation and bone regeneration.

Keywords: Bone formation and bone regeneration; Bone tissue engineering; MSCs; Osteogenic differentiation; lncRNA.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone Regeneration / genetics
  • Cell Differentiation / genetics*
  • Humans
  • Mesenchymal Stem Cells / cytology*
  • Osteogenesis / genetics*
  • RNA, Long Noncoding / genetics*
  • Tissue Engineering

Substances

  • RNA, Long Noncoding